A5V4d

References
148. Akinyoola AL, Obiajunwa PO, Oginni LM. Septic arthritis in children.West African Journal of
Medicine 2006;25(2):119–23.
149. Tseng C-F, Fu Y-C, Fu L-S, et al. Clinical spectrum of Kawasaki disease in infants. Chinese
Medical Journal 2001;64(3):168–73.
150. Huang GY, Ma XJ, Huang M, et al. Epidemiologic pictures of Kawasaki disease in Shanghai
from 1998 through 2002. Journal of Epidemiology 2006;16(1):9–14.
151. Neighbour R. The inner consultation. 1st edn. Lancaster, MTP; 1987.
152. Swingler GH, Zwarenstein M. Chest radiograph in acute respiratory infections in children.
(Cochrane Review). In: Cochrane Database of Systematic Reviews, Issue 3, 2005. Oxford: Update
Software.
153. Feder HM Jr. Occult pneumococcal bacteremia and the febrile infant and young child. Clinical
Pediatrics1980;19(7):457–62.
154. Goh PL, Lee SW, Wong EH. Predictors of serious bacterial infection in children aged 3 to 36
months with fever without source. Singapore Medical Journal 2006;47(4):276–80.
155. Rothrock SG, Harper MB, Green SM, et al. Do oral antibiotics prevent meningitis and serious
bacterial infections in children with streptococcus pneumoniae occult bacteremia? A metaanalysis.Pediatrics
1997; 99(3):438–44.
156. Rothrock SG, Green SM, Harper MB, et al. Parenteral vs oral antibiotics in the prevention of
serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a metaanalysis.
Academic Emergency Medicine 1998;5(6):599–606.
157. Damoiseaux RA, van Balen FA, Hoes AW, et al. Primary care based randomised, double
blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. British
Medical Journal 2000;320(7231):350–4.
158. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of
macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New England
Journal of Medicine 1997;337(7):441–7.
159. Hahne SJ, Charlett A, Purcell B, et al. Effectiveness of antibiotics given before admission in
reducing mortality from meningococcal disease: systematic review. British Medical Journal
2006;332(7553):1299–303.
160. Harnden A, Ninis N, Thompson M, et al. Parenteral penicillin for children with meningococcal
disease before hospital admission: case–control study. British Medical Journal 2006;332(7553):1295–
8.
161. Martin D, Kieft C, Miller J. The epidemiology of meningococcal disease in New Zealand in
1998. 1999.
162. Baker RC, Tiller T, Bausher JC, et al. Severity of disease correlated with fever reduction in
febrile infants. Pediatrics 1989;83(6):1016–9.
163. Baraff LJ, Oslund SA, Schriger DL, et al. Probability of bacterial infections in febrile infants
less than three months of age: A meta-analysis. Pediatric Infectious Disease Journal 1992;11(4):257–
65.
164. Dagan R, Sofer S, Philip M, et al. Ambulatory care of febrile infants younger than 2 months of
age classified as being at low risk for having serious bacterial infections. Journal of Pediatrics
1988;112(3):355–60.
165. van RossumAM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of
infection in neonates and children.Lancet Infectious Diseases 2004;4(10):620–30.
166. Carrol ED, Newland P, Riordan FAI, et al.Procalcitonin as a diagnostic marker of
meningococcal disease in children presenting with fever and a rash. Archives of Disease in Childhood
2002;86(4):282–5.
279